243 related articles for article (PubMed ID: 22132891)
21. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
[TBL] [Abstract][Full Text] [Related]
22. [Girl with IPEX syndrome with low expression of Foxp3].
Horiuchi S; Ishiguro A; Nakagawa T; Shoji K; Nagai A; Arai K; Horikawa R; Kawai T; Watanabe N; Onodera M
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):526-32. PubMed ID: 23291488
[TBL] [Abstract][Full Text] [Related]
23. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Rao A; Kamani N; Filipovich A; Lee SM; Davies SM; Dalal J; Shenoy S
Blood; 2007 Jan; 109(1):383-5. PubMed ID: 16990602
[TBL] [Abstract][Full Text] [Related]
24. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.
d'Hennezel E; Bin Dhuban K; Torgerson T; Piccirillo CA
J Med Genet; 2012 May; 49(5):291-302. PubMed ID: 22581967
[TBL] [Abstract][Full Text] [Related]
25. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes.
Caudy AA; Reddy ST; Chatila T; Atkinson JP; Verbsky JW
J Allergy Clin Immunol; 2007 Feb; 119(2):482-7. PubMed ID: 17196245
[TBL] [Abstract][Full Text] [Related]
26. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
[TBL] [Abstract][Full Text] [Related]
27. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.
Gavin MA; Torgerson TR; Houston E; DeRoos P; Ho WY; Stray-Pedersen A; Ocheltree EL; Greenberg PD; Ochs HD; Rudensky AY
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6659-64. PubMed ID: 16617117
[TBL] [Abstract][Full Text] [Related]
28. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Burroughs LM; Torgerson TR; Storb R; Carpenter PA; Rawlings DJ; Sanders J; Scharenberg AM; Skoda-Smith S; Englund J; Ochs HD; Woolfrey AE
J Allergy Clin Immunol; 2010 Nov; 126(5):1000-5. PubMed ID: 20643476
[TBL] [Abstract][Full Text] [Related]
29. Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Hashimura Y; Nozu K; Kanegane H; Miyawaki T; Hayakawa A; Yoshikawa N; Nakanishi K; Takemoto M; Iijima K; Matsuo M
Pediatr Nephrol; 2009 Jun; 24(6):1181-6. PubMed ID: 19189134
[TBL] [Abstract][Full Text] [Related]
30. Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.
Colobran R; Álvarez de la Campa E; Soler-Palacín P; Martín-Nalda A; Pujol-Borrell R; de la Cruz X; Martínez-Gallo M
Clin Immunol; 2016 Feb; 163():60-5. PubMed ID: 26748374
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China.
An YF; Xu F; Wang M; Zhang ZY; Zhao XD
Scand J Immunol; 2011 Sep; 74(3):304-309. PubMed ID: 21595732
[TBL] [Abstract][Full Text] [Related]
32. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
Passerini L; Di Nunzio S; Gregori S; Gambineri E; Cecconi M; Seidel MG; Cazzola G; Perroni L; Tommasini A; Vignola S; Guidi L; Roncarolo MG; Bacchetta R
Eur J Immunol; 2011 Apr; 41(4):1120-31. PubMed ID: 21400500
[TBL] [Abstract][Full Text] [Related]
33. Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4
Zemmour D; Charbonnier LM; Leon J; Six E; Keles S; Delville M; Benamar M; Baris S; Zuber J; Chen K; Neven B; Garcia-Lloret MI; Ruemmele FM; Brugnara C; Cerf-Bensussan N; Rieux-Laucat F; Cavazzana M; André I; Chatila TA; Mathis D; Benoist C
Nat Immunol; 2021 May; 22(5):607-619. PubMed ID: 33833438
[TBL] [Abstract][Full Text] [Related]
34. Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Huang Q; Liu X; Zhang Y; Huang J; Li D; Li B
J Genet Genomics; 2020 Jan; 47(1):17-26. PubMed ID: 32081609
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation.
Narula M; Lakshmanan U; Borna S; Schulze JJ; Holmes TH; Harre N; Kirkey M; Ramachandran A; Tagi VM; Barzaghi F; Grunebaum E; Upton JEM; Hong-Diep Kim V; Wysocki C; Dimitriades VR; Weinberg K; Weinacht KG; Gernez Y; Sathi BK; Schelotto M; Johnson M; Olek S; Sachsenmaier C; Roncarolo MG; Bacchetta R
J Allergy Clin Immunol; 2023 Jan; 151(1):233-246.e10. PubMed ID: 36152823
[
